rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2008-3-3
|
pubmed:abstractText |
Pancreatic cancer risk has been linked to chronic pancreatitis and periodontitis, suggesting a role for inflammation in disease etiology. Myeloperoxidase (MPO) and superoxide dismutase (SOD2) are enzymes that regulate reactive oxygen species and contain recognized single nucleotide polymorphisms (SNPs) that confer altered enzyme activity.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0008-543X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
112
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1037-42
|
pubmed:meshHeading |
pubmed-meshheading:18205184-Adenocarcinoma,
pubmed-meshheading:18205184-Adult,
pubmed-meshheading:18205184-Aged,
pubmed-meshheading:18205184-Aged, 80 and over,
pubmed-meshheading:18205184-Female,
pubmed-meshheading:18205184-Genetic Predisposition to Disease,
pubmed-meshheading:18205184-Humans,
pubmed-meshheading:18205184-Male,
pubmed-meshheading:18205184-Middle Aged,
pubmed-meshheading:18205184-Pancreatic Neoplasms,
pubmed-meshheading:18205184-Peroxidase,
pubmed-meshheading:18205184-Polymorphism, Genetic,
pubmed-meshheading:18205184-Risk,
pubmed-meshheading:18205184-Superoxide Dismutase
|
pubmed:year |
2008
|
pubmed:articleTitle |
Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma.
|
pubmed:affiliation |
Department of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Hospital, Toronto, Ontario, Canada.
|
pubmed:publicationType |
Journal Article
|